X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1343) 1343
Publication (192) 192
Book Review (40) 40
Book Chapter (22) 22
Conference Proceeding (6) 6
Dissertation (2) 2
Book / eBook (1) 1
Data Set (1) 1
Government Document (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (918) 918
immunotherapy (820) 820
humans (611) 611
oncology (585) 585
pd-l1 (517) 517
cancer (508) 508
immunology (419) 419
pd-l1 protein (395) 395
pd-1 (383) 383
lymphocytes (382) 382
tumors (377) 377
immune checkpoint (316) 316
animals (315) 315
lymphocytes t (305) 305
melanoma (276) 276
apoptosis (275) 275
pd-1 protein (274) 274
t cells (258) 258
antigens (253) 253
chemotherapy (224) 224
immune system (220) 220
dendritic cells (217) 217
cancer therapies (216) 216
female (216) 216
care and treatment (212) 212
metastasis (209) 209
expression (207) 207
ligands (201) 201
t-cells (194) 194
pd-l1 expression (190) 190
clinical trials (188) 188
cytotoxicity (181) 181
review (177) 177
nivolumab (172) 172
immune response (168) 168
immunotherapy - methods (165) 165
lung cancer (165) 165
patients (160) 160
health aspects (155) 155
research (153) 153
blockade (146) 146
male (146) 146
pembrolizumab (146) 146
ipilimumab (145) 145
mice (145) 145
tumor-infiltrating lymphocytes (143) 143
ctla-4 (141) 141
cell death (140) 140
cytokines (140) 140
biomarkers (139) 139
medical prognosis (139) 139
anti-pd-l1 antibody (138) 138
safety (138) 138
metastases (137) 137
vaccines (137) 137
neoplasms - immunology (132) 132
programmed cell death 1 receptor - antagonists & inhibitors (128) 128
medicine & public health (127) 127
b7-h1 antigen - metabolism (125) 125
open-label (124) 124
b7-h1 antigen - immunology (122) 122
proteins (122) 122
antibodies, monoclonal - therapeutic use (120) 120
analysis (119) 119
programmed cell death 1 receptor - immunology (118) 118
medicine, research & experimental (117) 117
gene expression (116) 116
article (115) 115
medical research (112) 112
regulatory t-cells (111) 111
tumor microenvironment (111) 111
therapy (110) 110
immunity (108) 108
b7-h1 antigen - antagonists & inhibitors (105) 105
survival (105) 105
cd8 antigen (104) 104
middle aged (103) 103
medicine (102) 102
pd-1 blockade (102) 102
breast cancer (99) 99
t cell receptors (99) 99
antibodies (98) 98
cell biology (98) 98
prognosis (98) 98
activation (97) 97
ctla-4 protein (96) 96
neoplasms - therapy (95) 95
monoclonal antibodies (94) 94
drug therapy (92) 92
immunoglobulins (92) 92
aged (90) 90
t-lymphocytes - immunology (90) 90
antineoplastic agents - therapeutic use (89) 89
antitumor immunity (89) 89
adult (88) 88
multidisciplinary sciences (88) 88
neoplasms. tumors. oncology. including cancer and carcinogens (87) 87
responses (85) 85
mutation (84) 84
programmed cell death 1 receptor - metabolism (84) 84
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1349) 1349
French (6) 6
German (4) 4
Japanese (4) 4
Chinese (2) 2
Czech (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 04/2018, Volume 128, Issue 4, pp. 1338 - 1354
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 02/2018, Volume 497, Issue 1, pp. 394 - 400
Immunotherapy is gathering momentum as a kind of important therapy for cancer patients. However, monotherapies have limited efficacy in improving outcomes and... 
CD4+ Foxp3+ regulatory T cells | PD-L1 | Vaccine | Immune evasion | HER2 | regulatory T cells | CD4 | Foxp3 | TARGET | RECOGNITION | BIOCHEMISTRY & MOLECULAR BIOLOGY | FUTURE | BREAST-CANCER | CD4(+) Foxp3(+) regulatory T cells | OVEREXPRESSION | ONCOGENE | THERAPY | BIOPHYSICS | HER-2/NEU | T-CELLS
Journal Article
Journal Article
International Journal of Cancer, ISSN 0020-7136, 05/2018, Volume 142, Issue 10, pp. 2106 - 2117
Eliminating cancer stem cells (CSCs) is a key issue in eradicating tumor. The streptavidin–granulocyte‐macrophage‐colony stimulating factor (SA–GM‐CSF)... 
vaccine | program death receptor‐1 | cancer stem cell | bladder cancer | immune checkpoints | program death receptor-1 | T-Lymphocyte Subsets - immunology | Cancer Vaccines - pharmacology | Dendritic Cells - immunology | Neoplastic Stem Cells - immunology | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Carcinoma, Transitional Cell - therapy | Programmed Cell Death 1 Receptor - biosynthesis | Cytokines - blood | Cytokines - immunology | Mice, Inbred C57BL | Granulocyte-Macrophage Colony-Stimulating Factor - pharmacology | Random Allocation | B7-H1 Antigen - immunology | Cancer Vaccines - immunology | Animals | Granulocyte-Macrophage Colony-Stimulating Factor - immunology | Carcinoma, Transitional Cell - immunology | Mice, Nude | B7-H1 Antigen - biosynthesis | Urinary Bladder Neoplasms - therapy | Urinary Bladder Neoplasms - immunology | Cell Line, Tumor | Mice | Programmed Cell Death 1 Receptor - immunology | CD8-Positive T-Lymphocytes - immunology | COLONY-STIMULATING FACTOR | ACQUIRED-RESISTANCE | LUNG-CANCER | TUMOR-ERADICATION | THERAPY | ONCOLOGY | IMMUNOTHERAPY | PROSTATE-CANCER | CARCINOMA | PD-1/PD-L1 BLOCKADE | T-CELLS | Vaccines | T cells | Bladder cancer | Immunotherapy | Stem cells | Therapy | CD8 antigen | Bladder | Stem cell transplantation | Lymphocytes T | Macrophages | Anticancer properties | Cancer vaccines | Lymphocytes | Combined vaccines | Streptavidin | Foxp3 protein | Colony-stimulating factor | Immune system | Immune response | Tumor cells | CD4 antigen | Signaling | Antitumor activity | Interferon | Leukocytes (granulocytic) | Cancer
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 04/2016, Volume 65, Issue 4, pp. 383 - 392
Journal Article
Journal Article